Table III.
Kaplan-Meier estimator analysis for overall survival rate of patients with medulloblastoma.
| Clinicopathological characteristics | STQ2 (STQ1, STQ3), months | P-valuea |
|---|---|---|
| Age, years | ||
| ≤3 | 20 (13, 21) | 0.161 |
| >3 | 41 (20.5, 55) | |
| Sex | ||
| Male | 41 (19, 53) | 0.585 |
| Female | 40 (24, 56) | |
| WHO histological subtype | ||
| Classic | 40 (19.75, 55) | 0.820 |
| Desmoplastic | 37.5 (17.75, 60.75) | |
| Residual tumor size, cm2 | ||
| <1.5 | 40 (20, 54) | 0.001 |
| ≥1.5 | 19 (11, 25) | |
| Metastatic status | ||
| M0 | 32.5 (14.75, 53.25) | 0.562 |
| M1 | 41.5 (20, 55) | |
| Tumor risk | ||
| Standard | 40 (19.5, 53.5) | 0.352 |
| High | 26 (19, 57) | |
| Differentiation level | ||
| Undifferentiated | 38 (14, 53.5) | 0.273 |
| Differentiated | 41 (24, 55) | |
| SPOPL expression | ||
| Low | 36.5 (19, 53.5) | 0.026 |
| High | 41.5 (33.25, 57) |
a
Log-rank test. ST, survival time; Q, interquartile range; WHO, World Health Organization; SPOPL, Speckle-type POZ protein-like.